0 CHECKOUT

PRODUCT FILTERS

REGION

1,006
90
64
61
53

COUNTRY

58
13
11
8
6

CATEGORIES

  • 73
  • 124
  • 60
  • 54
  • 35
  • 33
  • 10
  • 10
  • 11
  • 14

PRICE

543
799
1,663
2,767

PUBLISHED

59
237
601
2,767

PRODUCT TYPE

2,663
84
7
6
2
2
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

2,767 Products

Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 12 full...

Published:  January 2014
Price:  From

US Skin Cancer Drug Pipeline Analysis

The market for skin cancer in the US is expected to grow significantly owing to reasons like increasing number of patients and entry of new therapies which are in the pipeline Additionally, the organic...

Published:  January 2014
Price:  From

Complex General Surgical Oncology: a Case-Based Approach (Vol 2)

This is the second volume of a two part work. This first volume focused on a variety of breast pathologies, followed by examination of endocrine, soft tissue and esophageal malignancies. The thirteen...

Published:  January 2014
Price: 

Europe Lung Cancer Drug Pipeline Analysis

The most common type of cancer in terms of incidence and mortality rate is Lung cancer Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which...

Published:  January 2014
Price:  From

US Cancer Vaccine Pipeline Analysis

Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments With the approval of the expensive prostate cancer vaccine, Provenge...

Published:  January 2014
Price:  From

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2013

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2013',...

Published:  December 2013
Price:  From

Rhabdomyosarcoma - Pipeline Review, H2 2013

Rhabdomyosarcoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Rhabdomyosarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2013
Price:  From

High-Grade Glioma - Pipeline Review, H2 2013

High-Grade Glioma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'High-Grade Glioma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2013
Price:  From

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2013

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2013', provides an overview of...

Published:  December 2013
Price:  From

Germ Cell Tumors - Pipeline Review, H2 2013

Germ Cell Tumors - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Germ Cell Tumors - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2013
Price:  From

Malignant Glioma - Pipeline Review, H2 2013

Malignant Glioma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Malignant Glioma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2013
Price:  From

Mycosis Fungoides - Pipeline Review, H2 2013

Mycosis Fungoides - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Mycosis Fungoides - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2013
Price:  From

Hepatic (Liver) Metastasis - Pipeline Review, H2 2013

Hepatic (Liver) Metastasis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hepatic (Liver) Metastasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

Published:  December 2013
Price:  From

Acute Promyelocytic Leukemia - Pipeline Review, H2 2013

Acute Promyelocytic Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acute Promyelocytic Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

Published:  December 2013
Price:  From

Thyroid Cancer - Pipeline Review, H2 2013

Thyroid Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Thyroid Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  December 2013
Price:  From

Retinoblastoma - Pipeline Review, H2 2013

Retinoblastoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Retinoblastoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  December 2013
Price:  From

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2013

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2013', provides an overview of the...

Published:  December 2013
Price:  From

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2013', provides an overview of the indication’s...

Published:  December 2013
Price:  From

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013

Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nonmelanomatous Skin Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

Published:  December 2013
Price:  From

Bladder Carcinoma - Pipeline Review, H2 2013

Bladder Carcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bladder Carcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

Published:  December 2013
Price:  From
Loading Indicator

Our Clients